SPEAKER INDEX    CONTENTS   INSERTS   
BERMAN          12     45     47     48     64     65  
BLAINE MERRITT     5  
CANNON          58     59     60     61     62  
CHESS           30     32     34     43     44     46     48     52     66  
                68  
DAVID WHITNEY     5  
GOODLATTE       66     67     68     69  
ISSA            62     64     70  
JOE KEELEY       5  
JOHNSON         26     42     46     51     56     59     60     63     64  
                65     67     68     69  
KELLER          49     50     51     52     53  
LOFGREN         53     55     56     57     58  
PERRY H. APELBAUM     4  
PHILIP G. KIKO     4  
RYAN VISCO       5  
SHANNA WINTERS     5  
SIMON           16     41     50     54     55     57     58     61     62  
                67     69  
SMITH            9     14     15     26     30     32     34     36     40  
                41     42     43     44     45     49     53     56     57  
                58     62     65     69     71  
THOMAS          37     53     55     59  

CONTENTS    SPEAKERS   INSERTS   
TESTIMONY OF EMERY SIMON, COUNSEL, THE BUSINESS SOFTWARE ALLIANCE (BSA)
                                                                 PAGE    16

TESTIMONY OF PHILIP S. JOHNSON, CHIEF PATENT COUNSEL, JOHNSON & JOHNSON, ON BEHALF OF THE 
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)
                                                                 PAGE    26

TESTIMONY OF ROBERT B. CHESS, CHAIRMAN, NEKTAR THERAPEUTICS, ON BEHALF OF THE BIOTECHNOLOGY 
INDUSTRY ORGANIZATION (BIO)
                                                                 PAGE    30

TESTIMONY OF JOHN R. THOMAS, PROFESSOR, GEORGETOWN UNIVERSITY LAW CENTER
                                                                 PAGE    36


INSERTS    SPEAKERS   CONTENTS   
NO INSERTS IN THIS HEARING